Selected published reports for 2007 and 2008

U.A. Matulonis, A.B. Kornblith, H. Lee, J. Bryan, C. Gibson, C. Wells, J. Lee, L. Sullivan, R.T. Penson. Long-Term Adjustment of Early-Stage Ovarian Cancer Survivors. International Journal of Gynecologic Cancer (in press)

Stephen A. Cannistra, Ursula A. Matulonis, Richard T. Penson, Julie Hambleton, Jakob Dupont, Howard Mackey, Jeffrey Douglas, Robert A. Burger, Deborah Armstrong, Robert Wenham, William McGuire. Phase II Study of Bevacizumab in Patients with Platinum-Resistant Ovarian Cancer or Primary Peritoneal Serous Cancer. J Clin Oncol. 2007 Nov; 20;25(33):5180-6

Olawaiye A, Lee L, Krasner C, Horowitz N. Treatment of squamous cell vulvar cancer with anti-EGFR tyrosine kinase inhibitor Tarceva. Gyn Onc. 2007;106: 628-30

Abstracts for 2007 and 2008

AACR/NCI/ EORTC Molecular Therapeutics Meeting, 10/07

• Phase II study of Cediranib (RECENTIN, AZD2171) in recurrent epithelial ovarian cancer: Ursula Matulonis, Suzanne Berlin

European Society of Gynaecological Oncology, 10/07

• Phase II of carbo/alimta in platinum-resistant recurrent ovarian cancer: Ursula Matulonis
• Phase I of Doxil+ iressa for recurrent ovarian cancer: Susana Campos